Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Letrozole and Bevacizumab in Hormone Receptor Positive Breast Cancer
NCT00461773Phase 2Terminated
- Sponsor
- Yale University
- Start
- Mar 2007
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, letrozole in breast cancer, sponsored by Yale University. Started Mar 2007; status: terminated.
02
Drugs
bevacizumabletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00461773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461773.